Tomiyama S

Keio University School of Medicine, Department of Neuropsychiatry, Japan, Tokyo.

3 papers

ArticleKetamine

Association between Intravenous Ketamine Treatment and Cognitive Function in Patients with Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-Controlled Trial.

Nomoto K, Ohtani Y, Yatomi T +19

Europe PMC2026
ArticlePsilocybin

Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations.

Yonezawa K, Hirata M, Takano H +7

Europe PMC2026
ArticleKetamine

Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial.

Ohtani Y, Tani H, Nomoto-Takahashi K +20

Europe PMC2024